Immunoglobulin VDJ recombination is associated with transcriptional activation of the Ig variable region elements. We have previously described a novel Ig mu chain protein and mRNA produced by pre-B cell hybrids from normal and X-linked agammaglobulinemic bone marrow. We have now characterized the mRNA encoding this protein and find that it is composed of a 5' leader sequence spliced to C mu (LS-C mu), lacking the variable (V), diversity (D), and joining (J) gene sequences. The leader sequence is encoded by a novel exon 16 kb upstream of the JH locus. Transcription of the germ line heavy chain locus from this LS exon results in transcriptional activation of the JH locus, apparently the initial step in commitment to B lymphoid development. Polymerase chain reaction amplification of normal bone marrow shows that these germ line LS-C mu transcripts are a product of bone marrow pre-B cells. Production of LS-C mu commences a sequential process of transcriptional activation, with concordant translation of Ig rearrangement intermediates, in the process of creating a productive VDJ rearrangement.
Introduction
The genes encoding the variable regions of immunoglobulin are assembled in developing lymphocytes by selection and recombination of diverse gene elements. The Ig heavy chain V region is formed by recombination of variable (VH),I' diversity (D) , andjoining (J) gene elements (1, 2) in an ordered rearrangement process (3) . First a D gene element is recombined to a JH segment, followed by recombination ofa VH to the formed DJH structure. The sequential steps of recombination are catalyzed by a single recombinase (4) . The steps of recombination are associated with transcriptional activation of the recombining gene elements, suggesting that the recombinase is directed in its sequential steps by control ofaccess (5, 6) . In VH to DJH recombination, the DJH intermediate is transcribed from promoters upstream of several of the D gene elements (7, 8) , and unrearranged VH elements are transcribed from the promoters required for mature VHDJHC$ transcription. Transcription of the unrearranged JH locus has been reported (6) , but the transcripts and promoter that directs this transcription have not been characterized.
The human antibody deficiency disease X-linked agammaglobulinemia (XLA) results from failure of B lymphocyte development (9) . Patients with the major phenotype of XLA have normal numbers of pre-B cells in bone marrow, but only limited numbers of mature B lymphocytes in peripheral circulation (10) . We have previously proposed that the arrest in B lymphoid development in XLA results from failure ofIg V(D)J recombination (1 1) . This proposal was based on the identification of truncated ,u chains produced as mRNA and translated polypeptides in pre-B cell hybrids derived from the bone marrow ofpatients with XLA. This novel transcript was identified in some pre-B cell hybrids from normal fetal liver, but was the only product identified in hybrids from three patients with XLA.
We have now characterized these truncated it chains, and report that they are novel transcripts of the unrearranged Ig heavy (H) chain locus, representing transcriptional activation of the JH locus. The transcripts are composed of a 5' leader sequence spliced to the It constant region (LS-CIA), lacking the V, D, or J sequence characteristic of the previously described DQ (DJH rearrangement) or mature , (VDJCgu). LS-Cgu is transcribed from an exon 16 kb upstream of the JH locus in the unrearranged H chain locus. Transcription from this exon entails transcriptional activation of the unrearranged JH elements. By polymerase chain reaction (PCR) amplification, we have identified LS-CIA transcripts in normal bone marrow, further indicating that it represents a normal product of VDJ recombination.
Methods
The cell hybrids are as described previously (1 1, 12) . Normal human bone marrow was obtained by iliac crest biopsy from a normal volunteer, with aspiration into preservative-free heparin as anticoagulant. Written informed consent was obtained following procedures reviewed and approved by the Committee on Clinical Investigation, Children's Hospital, Boston. Mononuclear cells were separated by buoyant density centrifugation on Ficoll-paque (Pharmacia Fine Chemicals, Piscataway, NJ), and adherent cells were removed by adherence to plastic petri dishes overnight. For nucleic acid preparation, cells were pelleted by centrifugation, the medium aspirated, and stored at -80°until used to make RNA or DNA.
RNA was isolated by guanidine-HCl lysis as described by Chirgwin et al. (13) , followed by differential ethanol precipitation to remove DNA. PolyA-containing sequences were enriched by chromatography in oligo-dT cellulose. cDNA was synthesized with cloned Moloney murine leukemia virus reverse transcriptase (Bethesda Research Laboratories, Gaithersburg, MD) using oligo-dT or random hexamers (Promega Corp., Madison, WI) for priming. A cDNA library was constructed from oligo-dT-primed cDNA by annealing dC-tailed cDNA into dGtailed pBR322. The insert from the CM plasmid pAHM2 and a 61-bp EcoRI-Hinf[ fragment at the 5' end ofCM (nt 47-108, see [9] ) were used to screen the library. The inserts of pAHM2 and Mb9 were later subcloned into pUC18. LS-CM sequence was determined by both Maxam and Gilbert's (14) and dideoxy methods (15) , and the sequence was determined for both strands. Genomic DNA was extracted, digested with restriction endonucleases, and Southern blotted to nitrocellulose (Schleicher & Schuell, Inc., Keene, NH) as described by Maniatis et al. (16) . 5' terminal cDNA probes from rb9 and 73 2-33 were EcoRI fragments of cDNA clones isolated by electrophoresis through a 5% acrylamide gel (14) . EcoRI sites are present at the 5' terminus of these cDNAs (added by adapters for cloning) and at nucleotide 47 of the Cu sequence.
Polymerase chain reaction amplifications were performed in a thermal cycler (Perkin-Elmer Cetus Instruments, Norwalk, CT) with buffers, dNTPs, and TaqI polymerase from Perkin-Elmer Cetus. cDNA for PCR was synthesized with random primers, and incorporation of [32P]dCTP in an aliquot used to quantitate the cDNA. Primers were synthesized by Dr. A. Whitehead (Harvard Medical School, Boston MA), using a synthesizer (Applied Biosystems, Inc., Foster City, CA). The primers used were two nested primers for CA: 212LS 5' CCTTCTCTACAGAAGCCT -181 to -163 of 21-2 (VHI). These primers were derived from sequences published by Berman et al. (17) . A map ofthe Ig H chain locus, and the positions ofthese primers is given in Fig. 1 . The positions listed are nucleotides upstream from the 5' end ofthe FR I sequence, which places them in comparable positions to LSP with respect to the leader sequence first exon of these VH gene elements. cDNA was first amplified with CMIII as 3' primer. If no product was detected in an agarose gel, 1 Ml of a 1:20 dilution of the primary PCR was reamplified with either CMIII or CMI nested primer.
The conditions for PCR amplification were 940 (denaturation) for 1 min, 70 (annealing) for 1 min, 72 (reaction) for 3 min, for 30 cycles.
The annealing temperature was reduced to 650 for the LSP/CMIII reaction with normal bone marrow. Precautions were taken to prevent cross-contamination. Primers to amplify a fragment entirely within CM were used as positive control for amplification. These primers: CM4R 5' CAACTTGGTGGACTTGTTCAGGAAGATGCT +700 to +730 reverse complement of CM coding strand and CM5F 5' AAGACGTGCCTCTTCCAGTGATTG +299 to +323 of CM coding yielded a 433-bp amplification product. We used these primers as control in the following way: All reagents for amplification of an experimental cDNA except primers were mixed in a single tube. These reagents included the test cDNA and Taql polymerase. 98-Ml aliquots were placed in individual tubes and the relevant primers (e.g., 61 RILS and CMIII, or CM4R and CM5F) were added, followed immediately by thermal cycling for amplification. The CM4R/CM5F reaction then served as a test for addition of all necessary reagents for the amplification reaction and provided a control for comparison of amplification between experiments run at different times.
Amplification products were identified by Southern blotting ofsamples in agarose gels. The DNA was transferred either to nitrocellulose as previously described (16) or to Sure Blot Hybridization Membrane (Oncor Inc., Gaithersburg, MD) following the manufacturer's instructions. Blots were probed with the insert CM fragment from the pMHM2 plasmid. shown. The LSP primer yielded PCR amplification products with both germ line and mature transcripts (see Fig. 2 and Results). The 6 1RILS, 19IILS, and 212LS primers yielded PCR amplification product only with mature transcripts (see Results).
Germ LineM Chain Transcripts 2047
Phage clones spanning the JH to C14 intron were CH 4-22 (a twin to CH 4-38 [18] ) and CH 28-6, provided by P. Leder (Harvard Medical School), were as described by Ravetch et al. (18) and clone C7p6.2 was as described by Rabbitts et al. (19) . Cosmids CI7pl, c17p3, and CosM6, provided by H. Schroeder (University ofAlabama at Birmingham) and D. Cox (Hospital for Sick Children, Toronto), were as described by Schroeder et al. (20) .
Results
cDNA sequence encoding the truncated ,u chain. Four pre-B cell hybrids were previously described (1 1). LSM-T, LSM-A, and LSM-SB21 resulted from fusion of mononuclear cells from bone marrow of three different patients with X-linked agammaglobulinemia. LSH6 was a clone derived from fusion with normal fetal liver pre-B cells. This clone was selected for study because it produced a truncated ,u chain that comigrated with the q chain produced by the XLA hybrids. The LSM 2.7 human myeloma used as fusion partner made no detectable Ig as protein or RNA, and had deleted the CQu gene (12, and unpublished results). The four hybrids (LSM-T, LSM-A, LSM-SB2 1, and LSH6) were previously characterized to produce truncated ,g heavy chain without variable region as both mRNA and polypeptide. ,g chain proteins were reduced in size to 54 and 57 kD, compared with 66 and 69 kD for normal ,A chain (secretory and membrane forms). mRNA-encoding ,u chain was reduced in size, due to absence of 300 nt of 5' terminal sequence encoding the V region.
To determine the 5' terminus of the truncated u chains, a cDNA library was constructed by oligo-dT priming of mRNA from the LSH6 hybrid. Two clones encoding A chain were isolated. Restriction mapping of the clones confirmed that there were no deletions of the Cu sequence. The sequence of the clones was determined from the EcoRI site at nucleotide 47 of CM. The sequence lacks VH, D, or JH gene sequence ofmature zt chain or previously characterized immature D,. In place ofthis sequence, one clone (,ub9) has an 88-nt sequence that has near identity to the first LS exon of two human VH gene elements ( Fig. 2) (21) . The second clone has an identical sequence but extends only 63 nt upstream of Cu. The putative LS has an initiation codon (ATG) 61 nt upstream ofthe 5' terminus of C '4 and an open reading frame downstream. The ATG is in phase for translation ofCu. Compared with the product ofprimer-extension experiments, the longer clone is missing 65 nt of the full message, presumably 5' untranslated sequence.
Because of the size of the cDNA sequence, its open reading frame, and the absence of other detectable g chain message, it seems likely that this truncated message encodes the 54/57 kD protein identified in the pre-B cell hybrids. Since leader sequences are removed from the nascent polypeptide with passage into the lumen of the endoplasmic reticulum, this truncated polypeptide is Cu, and the transcript is LS-Cu. This novel u chain is the product ofthe pre-B parents ofthese hybrid cells. The myeloma parent of these hybrids could not have contributed the novel , chains because it lacks the Cg gene by Southern blotting and produces no detectableu chain RNA, either by Northern blotting or by PCR amplification (unpublished results).
LS-CM is a product ofnormal pre-B cells. Immune fluorescence experiments previously suggested that some pre-B cells from normal bone marrow produced g chain without V region antigen (11) . To determine whether LS-Cu is a product of (these) normal pre-B cells, we examined normal bone marrow directly by PCR amplification. cDNA prepared from total RNA of normal human bone marrow was amplified with primers derived from CMu and LS. A DNA fragment of 360 bp, the size predicted for the 5' terminus of LS-Cg with these primers, was identified (Fig. 3 ). This product was isolated from a gel, reamplified, and cloned into pUC18. The sequence of this molecule has near identity to the LS cDNA clone from the LSH6 pre-B cell hybrid ( Fig. 3 B) . The three nucleotides that differ are conservative for known leader sequence functions. The differences might result from an artifact ofPCR amplification. However, isolation of seven independently derived PCR clones with this sequence from this sample of normal bone marrow leads us to suggest that this sequence represents poly- 
pb9 GAG TTT GGG CTG ACC TGG GTT TTC CTC GTT GCT CTT TTA A GA Cy
pB9 Met Glu Phe Gly Leu Thr Trp Val Phe Leu Val Ala Ile Leu Lys LS-CIA is transcribed before recombination. Southern blotting of the JH locus from the pre-B cell hybrids suggests that LS-C/I results from transcriptional activation of the Ig heavy chain locus before recombination. HindIII/BamHI double digestion was used to separate the JH locus from CQ. Genomic DNA from the four pre-B cell hybrids contained a 7-kb band that comigrates with the embryonic (unrearranged) JH locus band from an unrearranged T cell line (Fig. 4) . This band is present against a background of multiple rearranged JH bands that are contributed by the myeloma parent ofthe hybrids, and is the only band unique to the hybrid cells that are shared in all four hybrids. All (single element family that is most proximal to CM) and 1-91I (VH4 gene family) and 21-2 (VHl gene family). Amplification product was identified only with the LSP primer derived from the Ab9 sequence (data not shown), indicating that LS-CIA results from transcription from a specific LS exon.
Mapping of the LS exon. The absence of transcriptional activation of VH gene elements suggests that LS-CM results from transcription ofa specific LS exon upstream ofCM. Direct cloning of the LS exon has been hindered by the near identity of ub9 with the leader sequence first exons of some VH gene elements, and the apparent polymorphism of the LS between different individuals. As an alternate approach, we have assumed that the LS exon lies between the VH6 gene element, the most 3' VH gene element, and CI, and restriction mapped a collection ofplasmid, phage, and cosmids spanning this region.
Nelson et al. (22) identified transcriptional activation ofthe Cl locus arising from the JH to CIO intron. Termed sterile 0 transcripts, they have not been found to be processed into mRNA or to yield a sequence that can be translated. To rule out LS-Cg transcription arising from this intron, we examined phage clones that span this region. A battery ofLS probes, both oligonucleotides and cDNA, did not hybridize with Southern blots of these clones (the phages used are shown in Fig. 5 , the negative blot is not shown). The plasmid clone C7p6.2 from T. Rabbitts (Medical Research Council Laboratory for Molecular Biology, Cambridge, England) was examined also, but is not shown (19) . To allow for polymorphism, these hybridizations were carried out at reduced stringency (420 and 6X standard saline citrate [SSC] ). This suggests that LS transcription must arise from an exon upstream of the JH locus.
Southern blotting of cosmid clones spanning the region from the most 3' VH gene element, VH6, to the JH locus indicates that the LS exon lies 16-18 kb upstream ofJH 1. Examination ofthe cosmid clone cos,6 with 5' terminal fragments from the ,ub9 and 73 2-33 cDNAs identified a 9-kb HindIII fragment that is 14-23 kb upstream ofJHI (Fig. 5 ). The 1b9 cDNA probe was removed at temperatures above 480 and salt below 2X SSC, while the 73 2-33 probe was resistant to melting to 550 and 0.1 X SSC, further evidence for polymorphism in the LS. Digestion of cosu6 with additional enzymes refined this map, locating the LS exon to a 2.3-kb SacI fragment that lies 14-16 kb upstream of JH1. No additional fragments that hybridize with LS probes were found on the other cosmid clones extending to the VH6 gene element (Fig. 5 ). This location for the LS exon is exactly analogous to the K°promoter upstream ofthe JK locus (23) , and suggests that the LS exon serves as a transcriptional promoter for the JH locus. Transcription from the LS exon yields a 26-28-kb primary transcript with splice donor sites at the 3' end of the LS and at the 3' This product is translated into polypeptide. Alternate splicing from the JH element splice donor sites would yield 16-17-kb RNAs that likely could not be translated. These alternate products would not have been identified by PCR amplification.
Discussion
We have described a novel Ig H chain transcript that arises from an exon upstream of the JH locus before recombination. LS-Cyu production may represent the initial step in recombinational access for the unrearranged H chain locus, directing transcriptional of the JH elements before DJH recombination. The recombinase has been proposed to be directed in its sequential steps of catalysis by control of access (24) . This proposal is based on identification of transcription of the DJH intermediate and unrearranged VH gene elements in Abelson virus-transformed murine pre-B cells (5) . Transcriptional activation ofthe light chain JK locus has been described, and VK to JK recombination is associated with transcriptional activation from the K0 exon (6, 25) . The LS exon serves as an analogous promoter for the H chain, directing transcriptional activation of the unrearranged JH locus. LS-Cg transcripts are processed into mRNA and translated into polypeptide. The first three steps in Ig recombination are associated with transcriptional activation. The unrearranged JH locus is transcribed from the LS exon before D to JH recombination (6) . Unrearranged VH gene elements and the DJH intermediate step ofrecombination are transcribed during VH to DJH recombination (5, 6) . The murine K light chain locus has a leader sequence exon, K0, analogous to the human H chain LS exon (23, 25) . K0 has near identity to the first leader sequence exon of VK gene elements, and lies 3-4 kb upstream ofthe JK locus. Transcripts from the K0 exon are processed into truncated K chain mRNA. In addition to the Ig locus, T cell antigen receptor gene elements likely are transcribed. D(3 elements direct transcription and likely translation of the D3J3 intermediate (26) . Transcripts of Ta and TB have been described in human B cell precursor cell lines (27) , and appear to be transcribed in T cells as well (28) . Transcriptional activation ofgene elements during recombination ofIg and T cell antigen receptors appears to be a rule.
mRNA transcripts of the same size as LS-CA have been identified previously in murine cell lines, but not further characterized (29, 30) . Kemp 6) would not identify mRNA derived from an LS exon that was processed as LS-Cu. However, alternative processing of LS-Cq primary transcripts, using the splice donor sites at the 3' ends ofeach JH locus, would yield RNAs that amplify as ,0. We suggest that there is a murine analogue of LS-CQ and the LS exon, leaving open the question of how alternative processing of these transcripts is regulated.
A mechanical interpretation of the access model entails sequential activation, first of the JH locus, then of D gene elements for D to JH recombination, then ofVH gene elements for VH to DJH recombination. The linear arrangement ofthe gene elements does not fit with a strict interpretation of this model. One human D gene element is located within the JH gene locus (18) , and several D gene elements are upstream of the most 3' VH gene element (31) . An alternate explanation ofthe observed transcriptional activation is simply that the entire locus opens up in preparation for recombination, transcription occurs coincidentally, and the sequential steps of recombination are regulated by a secondary mechanism. This view is consistent with a report of differential regulation for D to JH versus VH to DJH recombination in murine transfection vectors (32) . In this view, conservation of transcriptional promoters upstream of the JH and JK loci, and of the D gene elements is not strictly required for recombination. Instead, they could then be viewed either as evolutionary relics, or could be of import for translation of the intermediate structures into protein.
The significance of translation of these immature products into protein is not clear. LS-Cg transcripts are clearly translated into truncated ,u chains by the pre-B cell hybrids previously described and likely represent the 3-5% of pre-B cells from normal bone marrow previously identified to be CI + VHby immune fluorescence (9) . Cell-free translation of LS-Cu from the pre-B cell hybrids showed that some ofthe mRNA includes the 3' Ymem exon necessary for insertion in the cell membrane, raising the possibility of these molecules posing as membrane
Ig. Dit intermediates are translated into protein in both murine and human cells (7, 8, 33) . Again, some of these molecules include the ,umem exon, and are known to be expressed as membrane Ig. The truncated g chains, both LS-CM and DQ, may combine with the light chain surrogates lambdaS and Vpre-B to form a pseudo-immunoglobulin molecule without variable region (34, 35) . Polypeptides with sequence predicted by the K0 nucleic acid sequence have been reported (36, 37) . The DB transcripts ofT cell antigen receptor have an upstream ATG initiation codon with following open reading frame with the properties of a leader sequence, suggesting that this intermediate may be translated as well (26) . The conservation of transcription and translation ofthe several steps ofrecombination in both murine and human cells is the strongest argument for a regulatory role of these intermediate products.
We have previously proposed that the failure ofB cell development in patients with XLA results from a failure of H chain VDJ recombination (1 1). VDJ recombination is the primary event in pre-B cells. LS-CQu was the only Ig product found in uncloned pre-B cell hybrids from three XLA patients. In contrast, only 3 of 15 pre-B cell hybrids derived from normal fetal liver produced LS-CQu (unpublished results). Determination of whether LS-Cgu is the predominant product of XLA bone marrow pre-B cells, by direct examination of the products of XLA bone marrow pre-B cells, will be reported in a later publication.
